Andrew Combs

Overview

Andrew Combs received an average of $2M in total compensation, including $364K in salary, at Prelude Therapeutics between 2020 and 2021.

Source: SEC filing on April 29, 2022.

Related executives

We found five more executives who work or worked at Prelude Therapeutics.

Krishna Vaddi

Prelude Therapeutics

Chief Executive Officer

Jane Huang

Prelude Therapeutics

Chief Medical Officer

Bryant Lim

Prelude Therapeutics

Chief Financial Officer

Peggy Scherle

Prelude Therapeutics

Chief Scientific Officer

Brian Piper

Prelude Therapeutics

Chief Financial Officer

News

You may also like